Instituto de Investigación Biomédica de A Coruña (INIBIC)
Centro de investigación
Domingo Andrés
Pascual Figal
Publicaciones en las que colabora con Domingo Andrés Pascual Figal (48)
2022
-
Comments on the 2021 ESC guidelines on cardiovascular disease prevention in clinical practice
Revista Española de Cardiología (English Edition), Vol. 75, Núm. 5, pp. 364-369
-
Prevalence, Incidence, and Outcomes of Hyperkalaemia in Patients with Chronic Heart Failure and Reduced Ejection Fraction from a Spanish Multicentre Study: SPANIK-HF Design and Baseline Characteristics
Journal of Clinical Medicine, Vol. 11, Núm. 5
-
Rationale and design of the pragmatic clinical trial tREatment with Beta-blockers after myOcardial infarction withOut reduced ejection fracTion (REBOOT)
European heart journal. Cardiovascular pharmacotherapy, Vol. 8, Núm. 3, pp. 291-301
-
Renal Function Impact in the Prognostic Value of Galectin-3 in Acute Heart Failure
Frontiers in Cardiovascular Medicine, Vol. 9
-
Serum potassium dynamics during acute heart failure hospitalization
Clinical Research in Cardiology, Vol. 111, Núm. 4, pp. 368-379
2021
-
A 3-Biomarker 2-Point-Based Risk Stratification Strategy in Acute Heart Failure
Frontiers in Physiology, Vol. 12
-
Sacubitril-Valsartan, Clinical Benefits and Related Mechanisms of Action in Heart Failure With Reduced Ejection Fraction. A Review
Frontiers in Cardiovascular Medicine, Vol. 8
-
Spanish Heart Transplant Registry. 32nd Official Report of the Heart Failure Association of the Spanish Society of Cardiology
Revista Espanola de Cardiologia, Vol. 74, Núm. 11, pp. 962-970
2020
-
Economic analysis of intermittent intravenous outpatient treatment with levosimendan in advanced heart failure in Spain
Revista Espanola de Cardiologia, Vol. 73, Núm. 5, pp. 361-367
-
Expert consensus statement on heart failure with reduced ejection fraction: beyond the guidelines
Revista Espanola de Cardiologia Suplementos, Vol. 20, Núm. SB, pp. 1-46
-
Hyperkalemia in heart failure patients in Spain and its impact on guidelines and recommendations: ESC-EORP-HFA Heart Failure Long-Term Registry
Revista Espanola de Cardiologia, Vol. 73, Núm. 4, pp. 313-323
-
NT-proBNP Response to Sacubitril/Valsartan in Hospitalized Heart Failure Patients With Reduced Ejection Fraction: TRANSITION Study
JACC: Heart Failure, Vol. 8, Núm. 10, pp. 822-833
-
Prevalence, clinical profile and prognostic implications of interatrial block in patients admitted for heart failure
REC: CardioClinics, Vol. 55, Núm. 3, pp. 155-164
-
Pronóstico al año en pacientes con insuficiencia cardiaca en España. Registro ESC-EORP-HFA Heart Failure Long-Term
REC: CardioClinics, Vol. 55, Núm. 4, pp. 207-216
-
Spanish Heart Transplant Registry. 31th Official Report of the Heart Failure Association of the Spanish Society of Cardiology
Revista Espanola de Cardiologia, Vol. 73, Núm. 11, pp. 919-926
2019
-
Acute heart failure congestion and perfusion status – impact of the clinical classification on in-hospital and long-term outcomes; insights from the ESC-EORP-HFA Heart Failure Long-Term Registry
European Journal of Heart Failure, Vol. 21, Núm. 11, pp. 1338-1352
-
Initiation of sacubitril/valsartan in haemodynamically stabilised heart failure patients in hospital or early after discharge: primary results of the randomised TRANSITION study
European Journal of Heart Failure, Vol. 21, Núm. 8, pp. 998-1007
-
Patient-Associated Predictors of 15- and 30-Day Readmission After Hospitalization for Acute Heart Failure
Current Heart Failure Reports, Vol. 16, Núm. 6, pp. 304-314
-
Sacubitril/valsartan eligibility and outcomes in the ESC-EORP-HFA Heart Failure Long-Term Registry: bridging between European Medicines Agency/Food and Drug Administration label, the PARADIGM-HF trial, ESC guidelines, and real world
European Journal of Heart Failure, Vol. 21, Núm. 11, pp. 1383-1397
2018
-
Efficacy and safety of intermittent intravenous outpatient administration of levosimendan in patients with advanced heart failure: the LION-HEART multicentre randomised trial
European Journal of Heart Failure, Vol. 20, Núm. 7, pp. 1128-1136